As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

Global drug discovery informatics market is expected to grow at a formidable rate of around 10% during the forecast period. The global drug discovery informatics market is driven by the growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases, renal disorders, respiratory problems, among others. This has drastically increased the patient pool requiring treatment for these diseases. The treatment of these diseases is quite expensive and for certain diseases such as diabetes, there is no treatment option available. Such diseases can only be controlled using medications. This in turn has increased the demand for novel drug molecules for treating these diseases, which in turn is expected to positively influence the market growth through 2025. Besides, technological advancements in the biotechnology and pharmaceutical industry is further expected to propel the market growth over the next few years. Also, increase in number of expired patents is further expected to create lucrative opportunities for the market growth during the forecast period. Furthermore, growing R&D activities for the development of biologics and biosimilars is expected to spur the market growth until 2025.

The global drug discovery informatics market is segmented based on component, function, mode, application, end user, company and region. Based on component, the market can be split into software and service. Among these, the software segment is expected to dominate the market owing to the widespread use of informatics software for efficient management, storage and analysis of data generated during the drug discovery process.

Regionally, the global drug discovery informatics market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, Asia Pacific is expected to witness significant growth in the overall drug discovery informatics market owing to the widespread growth of pharmaceutical and biotechnology companies in the region. Additionally, entry of major drug manufacturing players in the region owing to the availability of low-cost manufacturing facilities and low cost labor in the region, is expected to fuel the market growth over the coming years.

Major players operating in the global drug discovery informatics market include Jubilant Life Sciences Limited, IBM Corporation, Clarivate Analytics, Eurofins Scientific, Thermo Fisher Scientific, Accenture PLC, PerkinElmer Inc, Schrödinger, Inc., Certara L.P., Evotec AG and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of global drug discovery informatics market from 2015 to 2018.
  • To estimate and forecast the market size of global drug discovery informatics market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global drug discovery informatics market based on component, function, mode, application, end user, company and regional distribution.
  • To identify dominant region or segment in the global drug discovery informatics market.
  • To identify drivers and challenges for global drug discovery informatics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global drug discovery informatics market.
  • To identify and analyze the profile of leading players operating in global drug discovery informatics market.
  • To identify key sustainable strategies adopted by market players in global drug discovery informatics market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, vendors and presence of all major players across the globe.

TechSci Research calculated the market size of global drug discovery informatics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Drug discovery informatics service provider companies, vendors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to drug discovery informatics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendors, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global drug discovery informatics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Drug Discovery Informatics Market, By Component:
    • Software
    • Service
  • Global Drug Discovery Informatics Market, By Function:
    • Sequencing and Target Data Analysis
    • Docking
    • Molecular Modelling
    • Library & Database Preparation
    • Clinical Trial Data Management
    • Others
  • Global Drug Discovery Informatics Market, By Mode:
    • In-house Informatics
    • Outsourced
  • Global Drug Discovery Informatics Market, By Application:
    • Drug Discovery
    • Drug Development
  • Global Drug Discovery Informatics Market, By End User:
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Contract Research Organization (CROs)
    • Others
  • Global Drug Discovery Informatics Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global drug discovery informatics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global drug discovery informatics market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Drug Discovery Informatics

4.    Executive Summary

5.    Voice of Customer

6.    Global Drug Discovery Informatics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Component (Software v/s Service)

6.2.2.     By Function (Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation, Clinical Trial Data Management, Others)

6.2.3.     By Mode (In-house Informatics v/s Outsourced)

6.2.4.     By Application (Drug Discovery v/s Drug Development)

6.2.5.     By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs), Others)

6.2.6.     By Company (2019)

6.2.7.     By Region

6.3.  Product Market Map

7.    Asia-Pacific Drug Discovery Informatics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Component

7.2.2.     By Function

7.2.3.     By Mode

7.2.4.     By Application

7.2.5.     By End User

7.2.6.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Drug Discovery Informatics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Component

7.3.1.2.2.             By Function

7.3.1.2.3.             By Mode

7.3.1.2.4.             By Application

7.3.1.2.5.             By End User

7.3.2.     India Drug Discovery Informatics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Component

7.3.2.2.2.             By Function

7.3.2.2.3.             By Mode

7.3.2.2.4.             By Application

7.3.2.2.5.             By End User

7.3.3.     Australia Drug Discovery Informatics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Component

7.3.3.2.2.             By Function

7.3.3.2.3.             By Mode

7.3.3.2.4.             By Application

7.3.3.2.5.             By End User

7.3.4.     Japan Drug Discovery Informatics Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Component

7.3.4.2.2.             By Function

7.3.4.2.3.             By Mode

7.3.4.2.4.             By Application

7.3.4.2.5.             By End User

7.3.5.     South Korea Drug Discovery Informatics Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Component

7.3.5.2.2.             By Function

7.3.5.2.3.             By Mode

7.3.5.2.4.             By Application

7.3.5.2.5.             By End User

8.    Europe Drug Discovery Informatics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Component

8.2.2.     By Function

8.2.3.     By Mode

8.2.4.     By Application

8.2.5.     By End User

8.2.6.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Drug Discovery Informatics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Component

8.3.1.2.2.             By Function

8.3.1.2.3.             By Mode

8.3.1.2.4.             By Application

8.3.1.2.5.             By End User

8.3.2.     Germany Drug Discovery Informatics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Component

8.3.2.2.2.             By Function

8.3.2.2.3.             By Mode

8.3.2.2.4.             By Application

8.3.2.2.5.             By End User

8.3.3.     United Kingdom Drug Discovery Informatics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Component

8.3.3.2.2.             By Function

8.3.3.2.3.             By Mode

8.3.3.2.4.             By Application

8.3.3.2.5.             By End User

8.3.4.     Italy Drug Discovery Informatics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Component

8.3.4.2.2.             By Function

8.3.4.2.3.             By Mode

8.3.4.2.4.             By Application

8.3.4.2.5.             By End User

8.3.5.     Spain Drug Discovery Informatics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Component

8.3.5.2.2.             By Function

8.3.5.2.3.             By Mode

8.3.5.2.4.             By Application

8.3.5.2.5.             By End User

9.    North America Drug Discovery Informatics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Component

9.2.2.     By Function

9.2.3.     By Mode

9.2.4.     By Application

9.2.5.     By End User

9.2.6.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Drug Discovery Informatics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Component

9.3.1.2.2.             By Function

9.3.1.2.3.             By Mode

9.3.1.2.4.             By Application

9.3.1.2.5.             By End User

9.3.2.     Mexico Drug Discovery Informatics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Component

9.3.2.2.2.             By Function

9.3.2.2.3.             By Mode

9.3.2.2.4.             By Application

9.3.2.2.5.             By End User

9.3.3.     Canada Drug Discovery Informatics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Component

9.3.3.2.2.             By Function

9.3.3.2.3.             By Mode

9.3.3.2.4.             By Application

9.3.3.2.5.             By End User

10.  South America Drug Discovery Informatics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Component

10.2.2.  By Function

10.2.3.  By Mode

10.2.4.  By Application

10.2.5.  By End User

10.2.6.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Drug Discovery Informatics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Component

10.3.1.2.2.           By Function

10.3.1.2.3.           By Mode

10.3.1.2.4.           By Application

10.3.1.2.5.           By End User

10.3.2.  Argentina Drug Discovery Informatics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Component

10.3.2.2.2.           By Function

10.3.2.2.3.           By Mode

10.3.2.2.4.           By Application

10.3.2.2.5.           By End User

10.3.3.  Colombia Drug Discovery Informatics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Component

10.3.3.2.2.           By Function

10.3.3.2.3.           By Mode

10.3.3.2.4.           By Application

10.3.3.2.5.           By End User

11.  Middle East and Africa Drug Discovery Informatics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Component

11.2.2.  By Function

11.2.3.  By Mode

11.2.4.  By Application

11.2.5.  By End User

11.2.6.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Drug Discovery Informatics Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast